A critical breakthrough in cancer research is occurring with the use of nanobodies to reactivate mutated p53. This crucial malignant suppressor protein is frequently disabled in various forms of cancer, causing https://bookmarkfriend.com/story21991407/mini-antibodies-restore-tumor-suppressor-p53-new-new-pathway-for-malignant-therapy